GlassScriptPhysician profile
Cynthia Philip
NPI 1346653318
$40,890.31
in general payments reported to CMS, 2019-2025
10 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $60.69 · 2021: $555 · 2022: $15K · 2023: $7,380 · 2024: $1,916 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $21K · Food and Beverage: $3,620 · Grant: $294 · Education: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $20,531.22 |
| Food and Beverage | $3,620.13 |
| Grant | $294.12 |
| Education | $192.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $26,818.32 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Abbott Laboratories | $3,834.81 | 2019-2024 | Optis, Mitraclip, Cardiomems |
| Edwards Lifesciences Corporation | $3,006.62 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Teleflex LLC | $2,668.78 | 2025 | Guideliner, Turnpike |
| W. L. Gore & Associates, INC. | $1,683.12 | 2023 | Gore Cardioform Septal Occluder |
| Abiomed | $1,659.17 | 2023-2024 | Impella |
| Boston Scientific Corporation | $695.03 | 2019-2023 | |
| Cardiovascular Systems INC. | $433.56 | 2021-2023 | Diamondback Coronary, Diamondback Peripheral |
| Cardiva Medical, INC. | $65.45 | 2022 | |
| Medtronic Vascular, INC. | $25.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Philip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.